Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1999
11/17/1999EP0956012A1 Fatty acid treatment
11/17/1999EP0956002A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/17/1999EP0819135B1 Sugar-modified cytostatics
11/17/1999EP0805871B1 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen
11/17/1999EP0741726B1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/17/1999EP0738273B1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235608A Alkylated reapamycin derivatives
11/17/1999CN1235542A Falty acid treatment
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235124A Anti-cancer therapy agent of arsenic hexoxide (AS4O6) of natural chemical substance and its pharmaceutical composition
11/17/1999CN1235020A Medicinal products of superfined alpha-linolenic acid, preparing process and preparation thereof
11/17/1999CN1046521C Preparation of 4-deoxcide-4-epi-podophyllotoxin derivatives
11/17/1999CN1046516C Method for stabilizing compound DX-52-1 and lyophilized composiiton thereof
11/17/1999CN1046514C Melatonin agonist 'beta-carboline derivatives and analogs with naphthalenic structure, preparation thereof and their use as drugs
11/16/1999US5986131 RXR selective ligands
11/16/1999US5986108 Enzyme inhibitors
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985927 Medicaments for the selective treatment of tumor tissues
11/16/1999US5985924 Metastasis suppressory agents
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985909 Anticancer drugs used as prodrugs for antibody-directed enzyme-prodrug therapy (adept) and gene-directed enzyme-prodrug therapy (gdept) for cancer
11/16/1999US5985908 MCBI analogs of CC-1065 and the duocarmycins
11/16/1999US5985905 Useful for the treatment and/or prophylaxis of diseases associated with loss of bone mass, such as osteoporosis and related osteopenic diseases, paget's disease, hyperparathyroidism and related diseases, also antitumor
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985897 Benzothiphene compounds, intermediates, compositions, and methods
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/16/1999US5985876 Antitumor agents
11/16/1999US5985868 Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985839 Treating cancer, psoriasis, acne
11/16/1999US5985837 Cell growth inhibitor peptides; treating cancer in a mammal
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
11/16/1999US5985270 Antitumor
11/16/1999US5985268 Gamma-irradiated bacterial preparation having anti-tumor activity
11/16/1999US5985266 Sensitize tumors, retrovirus comprises operatively linked to a promoter a gene encoding a viral thymidine kinase; such that said tumor cells become transduced by said retrovirus and express said viral thymidine kinase gene;
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/16/1999US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2002864C (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057274A1 Human protease associated proteins
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057144A2 Human transcriptional regulator molecules
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057126A1 Novel anthracycline derivatives and their preparation
11/11/1999WO1999057117A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
11/11/1999WO1999057102A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999WO1999056779A1 Non-invasive methods to detect prostate cancer
11/11/1999WO1999056773A2 Composition comprising tumor cells and extracts and method of using thereof
11/11/1999WO1999056769A2 Inhibition of helicobacter pylori proliferation
11/11/1999WO1999056739A1 A method for chemoprevention of prostate cancer
11/11/1999WO1999056697A2 Pharmaceutical composition
11/11/1999WO1999056535A1 Culture of sessile marine animals
11/11/1999WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
11/11/1999WO1999047563A3 Ribonucleotide polypeptides containing metal
11/11/1999WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1999042821A3 Treating cancer
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999029863A9 Human interferon-epsilon: a type i interferon
11/11/1999DE19838506A1 Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen The indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferations
11/11/1999DE19831579A1 Antikrebstherapiemittel aus Arsenhexoxid Anti-cancer therapeutics from Arsenhexoxid
11/11/1999DE19820599A1 New epothilone derivatives useful as pharmaceuticals and in plant protection
11/11/1999DE19820064A1 Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted Sulfonylcyanamide, processes for their preparation and their use as a medicament
11/11/1999CA2331863A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999CA2331627A1 Non-invasive methods to detect prostate cancer
11/11/1999CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2328459A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2327263A1 Human protease associated proteins
1 ... 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 ... 2211